PATENT CLAIM ANALYSIS

Application Number: 15993937
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-02
Patent Classification: ["514", "267000"]

Abstract:
The present invention provides tricyclic compounds, pharmaceutically acceptable salts, solvates, or hydrates thereof, having antimitotic activity, anti-multidrug resistance activity, for example P-glycoprotein inhibition, and antitumor activity, and which inhibit paclitaxel sensitive and resistant tumor cells. Also provided are methods of utilizing these compounds for treating tumor cells and inhibiting mitosis of cancerous cells.

Claim (Index 4):
The method of  claim 3  including wherein said compound includes stereoisomers thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.43182
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14719824', '15795801', '15283705', '13151536', '13151530']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8144757241993545
- 35 USC 102 Novelty (BERT): 0.5706935216167789
- Combined Prediction Score: 0.790097503941097
- Mean Citation Score: 447.678102
- Max Citation Score: 448.70337
- Similarity Product: 383.75604488728

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test